Wanbury Limited (BOM:524212)

Market Cap	8.97B
Revenue (ttm)	6.00B
Net Income (ttm)	305.30M
Shares Out	32.76M
EPS (ttm)	8.98
PE Ratio	30.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,393
Average Volume	6,637
Open	265.00
Previous Close	265.05
Day's Range	263.00 - 276.00
52-Week Range	155.00 - 330.00
Beta	0.28
RSI	46.47
Earnings Date	Jun 20, 2025

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive t...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 1,491
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524212

Financial Performance

In 2024, Wanbury's revenue was 6.00 billion, an increase of 4.15% compared to the previous year's 5.76 billion. Earnings were 305.30 million, a decrease of -45.44%.